Cardiovascular Information System Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Mode of Operation (Web based, Cloud based, On site), By System (CVIS, CPACS), By Region & Competition, 2021-2031F

May 2026 | 185 pages | ID: C004AFAD0E21EN
TechSci Research

Abstracts

The Global Cardiovascular Information System (CVIS) Market is projected to expand significantly, rising from USD 1.55 Billion in 2025 to USD 2.71 Billion by 2031, demonstrating a Compound Annual Growth Rate (CAGR) of 9.76%. A CVIS represents a specialized software solution crafted to manage both administrative and clinical data within cardiac care settings through the integration of medical imagery, patient records, and various reports. The market's growth is primarily fueled by the increasing incidence of heart pathologies, which necessitates streamlined workflow management and improved diagnostic precision in clinical environments. Furthermore, the growing demand for electronic health record (EHR) integration to ensure data continuity and operational efficiency supports the broader adoption of these platforms across diverse healthcare networks. However, market expansion faces notable hurdles, including the substantial costs associated with implementation and persistent challenges related to complex data interoperability. These financial and technical barriers can hinder the adoption of CVIS in smaller healthcare facilities, even amidst a rising patient volume. The critical need for robust management systems is underscored by high disease prevalence rates, which demand comprehensive data tracking. For instance, in 2024, approximately 127.9 million adults in the United States were affected by some form of cardiovascular disease, as reported by the American Heart Association.

Market Driver

The escalating prevalence of cardiovascular diseases serves as a primary driver, accelerating the global adoption of cardiovascular information systems. As the incidence of heart pathologies continues to rise, healthcare institutions are increasingly compelled to implement centralized digital platforms capable of managing extensive and intricate clinical datasets. These systems are crucial for optimizing workflows and ensuring that vital patient history and diagnostic imagery are readily accessible to care teams. The urgent need for such systems is further highlighted by mortality statistics; according to the American Heart Association's '2025 Heart Disease and Stroke Statistics' report from January 2025, cardiovascular disease was responsible for approximately 19.41 million global deaths in 2021. This substantial burden mandates scalable IT infrastructure to support high-volume patient management and enhance long-term care outcomes. Concurrently, the rapid integration of artificial intelligence (AI) and machine learning (ML) is fundamentally transforming the technical capabilities of these information systems. AI-driven tools are being embedded into cardiac software to automate image analysis, detect subtle anomalies, and prioritize urgent cases, thereby enhancing clinical decision-making. This technological evolution garners strong support from healthcare professionals who perceive automation as a viable solution to operational challenges. A Philips 'Future Health Index 2025: Cardiology Snapshot' from August 2025 indicated that 79% of cardiac care professionals believe AI can significantly reduce the burden of cardiovascular disease over time. The market's progressive trajectory is also evident in the increasing availability of regulatory-approved innovations. As per a Cardiovascular Business article from July 2025, 'Cardiology still No. 2 in FDA-cleared clinical AI algorithms', the FDA has cleared 116 cardiology-specific AI algorithms for clinical use, reflecting a robust and expanding ecosystem of diagnostic advancements ready for integration.

Market Challenge

The substantial cost of implementation, coupled with intricate data interoperability issues, poses a significant impediment to the expansion of the Global Cardiovascular Information System Market. These systems demand considerable upfront capital for software licensing, necessary hardware infrastructure, and comprehensive staff training, thereby creating a high barrier to entry for smaller healthcare facilities and rural clinics operating with limited budgets. Additionally, the technical complexities involved in integrating these specialized platforms with existing legacy electronic health records frequently lead to the creation of data silos. This absence of seamless connectivity diminishes the immediate operational value of the systems and discourages organizations from investing in digital transformation, as they anticipate potential disruptions to established clinical workflows without guaranteed improvements in efficiency. This financial strain directly hinders market growth, as healthcare providers often prioritize essential operational costs over technological upgrades. In situations where hospitals face constrained margins, capital-intensive IT projects are often among the first to be deferred or cancelled. This reluctance to invest is clearly observed in recent industry trends, where escalating expenses have compelled facilities to freeze spending on new technologies. According to the American Hospital Association in 2025, an estimated 94% of healthcare administrators expected to delay equipment upgrades as a strategy to manage financial pressures. Such fiscal constraints severely limit the accessible market for cardiovascular information systems, preventing widespread adoption despite the evident clinical need for more effective data management.

Market Trends

A defining trend within the cardiovascular information system market is the strong emphasis on interoperability standards and seamless data exchange. The current inability to access complete patient history across various disparate platforms creates critical bottlenecks, prompting CVIS solutions to evolve into unified hubs that consolidate records from both electronic health records (EHRs) and Picture Archiving and Communication Systems (PACS). The urgent necessity of this integration is highlighted by the operational inefficiencies it addresses; a Philips 'Future Health Index 2025: Cardiology Snapshot' from August 2025 revealed that nearly 80% of cardiac care professionals report losing clinical time due to incomplete or inaccessible patient data. Consequently, vendors are prioritizing the adoption of HL7 standards to ensure that vital information is immediately available at the point of care. Simultaneously, there is a growing momentum towards transitioning from free-text dictation to structured cardiovascular reporting to significantly enhance data utility. Unlike narrative reports, structured reporting employs standardized templates with discrete data fields, which facilitates automated registry submission and enables robust data mining capabilities. This shift not only improves billing accuracy but also considerably reduces the administrative workload on specialists. The efficiency gains are substantial; according to an AuntMinnie article from November 2025, 'Structured reporting tool cuts CCTA interpretation time', a study demonstrated that utilizing a structured reporting tool decreased the interpretation time per case by 40.2% compared to traditional workflows. This compelling evidence is driving healthcare facilities to adopt structured modules, aiming to mitigate physician burnout and accelerate diagnostic turnaround times.

Key Market Players

• Koninklijke Philips N.V.
• General Electric Company
• Cisco Systems Inc
• FUJIFILM Medical Systems USA Inc
• Siemens Healthcare GmbH
• Cerner Corp
• Lumedx Corp
• Digisonics Inc
• Honeywell International Inc
• McKesson Corporation

Report Scope

In this report, the Global Cardiovascular Information System Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

• Cardiovascular Information System Market, By Mode of Operation
• Web based
• Cloud based
• On site
• Cardiovascular Information System Market, By System
• CVIS
• CPACS
• Cardiovascular Information System Market, By Region
• North America
• United States
• Canada
• Mexico
• Europe
• France
• United Kingdom
• Italy
• Germany
• Spain
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• South America
• Brazil
• Argentina
• Colombia
• Middle East & Africa
• South Africa
• Saudi Arabia
• UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Cardiovascular Information System Market.

Available Customizations:

Global Cardiovascular Information System Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Contents

1. PRODUCT OVERVIEW

1.1. Market Definition
1.2. Scope of the Market
  1.2.1. Markets Covered
  1.2.2. Years Considered for Study
  1.2.3. Key Market Segmentations

2. RESEARCH METHODOLOGY

2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations

3. EXECUTIVE SUMMARY

3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends

4. VOICE OF CUSTOMER

5. GLOBAL CARDIOVASCULAR INFORMATION SYSTEM MARKET OUTLOOK

5.1. Market Size & Forecast
  5.1.1. By Value
5.2. Market Share & Forecast
  5.2.1. By Mode of Operation (Web based, Cloud based, On site)
  5.2.2. By System (CVIS, CPACS)
  5.2.3. By Region
  5.2.4. By Company (2025)
5.3. Market Map

6. NORTH AMERICA CARDIOVASCULAR INFORMATION SYSTEM MARKET OUTLOOK

6.1. Market Size & Forecast
  6.1.1. By Value
6.2. Market Share & Forecast
  6.2.1. By Mode of Operation
  6.2.2. By System
  6.2.3. By Country
6.3. North America: Country Analysis
  6.3.1. United States Cardiovascular Information System Market Outlook
    6.3.1.1. Market Size & Forecast
      6.3.1.1.1. By Value
    6.3.1.2. Market Share & Forecast
      6.3.1.2.1. By Mode of Operation
      6.3.1.2.2. By System
  6.3.2. Canada Cardiovascular Information System Market Outlook
    6.3.2.1. Market Size & Forecast
      6.3.2.1.1. By Value
    6.3.2.2. Market Share & Forecast
      6.3.2.2.1. By Mode of Operation
      6.3.2.2.2. By System
  6.3.3. Mexico Cardiovascular Information System Market Outlook
    6.3.3.1. Market Size & Forecast
      6.3.3.1.1. By Value
    6.3.3.2. Market Share & Forecast
      6.3.3.2.1. By Mode of Operation
      6.3.3.2.2. By System

7. EUROPE CARDIOVASCULAR INFORMATION SYSTEM MARKET OUTLOOK

7.1. Market Size & Forecast
  7.1.1. By Value
7.2. Market Share & Forecast
  7.2.1. By Mode of Operation
  7.2.2. By System
  7.2.3. By Country
7.3. Europe: Country Analysis
  7.3.1. Germany Cardiovascular Information System Market Outlook
    7.3.1.1. Market Size & Forecast
      7.3.1.1.1. By Value
    7.3.1.2. Market Share & Forecast
      7.3.1.2.1. By Mode of Operation
      7.3.1.2.2. By System
  7.3.2. France Cardiovascular Information System Market Outlook
    7.3.2.1. Market Size & Forecast
      7.3.2.1.1. By Value
    7.3.2.2. Market Share & Forecast
      7.3.2.2.1. By Mode of Operation
      7.3.2.2.2. By System
  7.3.3. United Kingdom Cardiovascular Information System Market Outlook
    7.3.3.1. Market Size & Forecast
      7.3.3.1.1. By Value
    7.3.3.2. Market Share & Forecast
      7.3.3.2.1. By Mode of Operation
      7.3.3.2.2. By System
  7.3.4. Italy Cardiovascular Information System Market Outlook
    7.3.4.1. Market Size & Forecast
      7.3.4.1.1. By Value
    7.3.4.2. Market Share & Forecast
      7.3.4.2.1. By Mode of Operation
      7.3.4.2.2. By System
  7.3.5. Spain Cardiovascular Information System Market Outlook
    7.3.5.1. Market Size & Forecast
      7.3.5.1.1. By Value
    7.3.5.2. Market Share & Forecast
      7.3.5.2.1. By Mode of Operation
      7.3.5.2.2. By System

8. ASIA PACIFIC CARDIOVASCULAR INFORMATION SYSTEM MARKET OUTLOOK

8.1. Market Size & Forecast
  8.1.1. By Value
8.2. Market Share & Forecast
  8.2.1. By Mode of Operation
  8.2.2. By System
  8.2.3. By Country
8.3. Asia Pacific: Country Analysis
  8.3.1. China Cardiovascular Information System Market Outlook
    8.3.1.1. Market Size & Forecast
      8.3.1.1.1. By Value
    8.3.1.2. Market Share & Forecast
      8.3.1.2.1. By Mode of Operation
      8.3.1.2.2. By System
  8.3.2. India Cardiovascular Information System Market Outlook
    8.3.2.1. Market Size & Forecast
      8.3.2.1.1. By Value
    8.3.2.2. Market Share & Forecast
      8.3.2.2.1. By Mode of Operation
      8.3.2.2.2. By System
  8.3.3. Japan Cardiovascular Information System Market Outlook
    8.3.3.1. Market Size & Forecast
      8.3.3.1.1. By Value
    8.3.3.2. Market Share & Forecast
      8.3.3.2.1. By Mode of Operation
      8.3.3.2.2. By System
  8.3.4. South Korea Cardiovascular Information System Market Outlook
    8.3.4.1. Market Size & Forecast
      8.3.4.1.1. By Value
    8.3.4.2. Market Share & Forecast
      8.3.4.2.1. By Mode of Operation
      8.3.4.2.2. By System
  8.3.5. Australia Cardiovascular Information System Market Outlook
    8.3.5.1. Market Size & Forecast
      8.3.5.1.1. By Value
    8.3.5.2. Market Share & Forecast
      8.3.5.2.1. By Mode of Operation
      8.3.5.2.2. By System

9. MIDDLE EAST & AFRICA CARDIOVASCULAR INFORMATION SYSTEM MARKET OUTLOOK

9.1. Market Size & Forecast
  9.1.1. By Value
9.2. Market Share & Forecast
  9.2.1. By Mode of Operation
  9.2.2. By System
  9.2.3. By Country
9.3. Middle East & Africa: Country Analysis
  9.3.1. Saudi Arabia Cardiovascular Information System Market Outlook
    9.3.1.1. Market Size & Forecast
      9.3.1.1.1. By Value
    9.3.1.2. Market Share & Forecast
      9.3.1.2.1. By Mode of Operation
      9.3.1.2.2. By System
  9.3.2. UAE Cardiovascular Information System Market Outlook
    9.3.2.1. Market Size & Forecast
      9.3.2.1.1. By Value
    9.3.2.2. Market Share & Forecast
      9.3.2.2.1. By Mode of Operation
      9.3.2.2.2. By System
  9.3.3. South Africa Cardiovascular Information System Market Outlook
    9.3.3.1. Market Size & Forecast
      9.3.3.1.1. By Value
    9.3.3.2. Market Share & Forecast
      9.3.3.2.1. By Mode of Operation
      9.3.3.2.2. By System

10. SOUTH AMERICA CARDIOVASCULAR INFORMATION SYSTEM MARKET OUTLOOK

10.1. Market Size & Forecast
  10.1.1. By Value
10.2. Market Share & Forecast
  10.2.1. By Mode of Operation
  10.2.2. By System
  10.2.3. By Country
10.3. South America: Country Analysis
  10.3.1. Brazil Cardiovascular Information System Market Outlook
    10.3.1.1. Market Size & Forecast
      10.3.1.1.1. By Value
    10.3.1.2. Market Share & Forecast
      10.3.1.2.1. By Mode of Operation
      10.3.1.2.2. By System
  10.3.2. Colombia Cardiovascular Information System Market Outlook
    10.3.2.1. Market Size & Forecast
      10.3.2.1.1. By Value
    10.3.2.2. Market Share & Forecast
      10.3.2.2.1. By Mode of Operation
      10.3.2.2.2. By System
  10.3.3. Argentina Cardiovascular Information System Market Outlook
    10.3.3.1. Market Size & Forecast
      10.3.3.1.1. By Value
    10.3.3.2. Market Share & Forecast
      10.3.3.2.1. By Mode of Operation
      10.3.3.2.2. By System

11. MARKET DYNAMICS

11.1. Drivers
11.2. Challenges

12. MARKET TRENDS & DEVELOPMENTS

12.1. Merger & Acquisition (If Any)
12.2. Product Launches (If Any)
12.3. Recent Developments

13. GLOBAL CARDIOVASCULAR INFORMATION SYSTEM MARKET: SWOT ANALYSIS

14. PORTER'S FIVE FORCES ANALYSIS

14.1. Competition in the Industry
14.2. Potential of New Entrants
14.3. Power of Suppliers
14.4. Power of Customers
14.5. Threat of Substitute Products

15. COMPETITIVE LANDSCAPE

15.1. Koninklijke Philips N.V.
  15.1.1. Business Overview
  15.1.2. Products & Services
  15.1.3. Recent Developments
  15.1.4. Key Personnel
  15.1.5. SWOT Analysis
15.2. General Electric Company
15.3. Cisco Systems Inc
15.4. FUJIFILM Medical Systems USA Inc
15.5. Siemens Healthcare GmbH
15.6. Cerner Corp
15.7. Lumedx Corp
15.8. Digisonics Inc
15.9. Honeywell International Inc
15.10. McKesson Corporation

16. STRATEGIC RECOMMENDATIONS

17. ABOUT US & DISCLAIMER